Betahistine Mesylate Tablets can generally be discontinued at any time, and its drug insert does not specify any discontinuation reaction or drug dependence effect of this drug, but the use of the drug and the course of treatment need to follow the doctor’s advice, so as not to affect the therapeutic effect.
Betahistine mesylate tablets are mainly used for vertigo and dizziness caused by Meniere’s syndrome, Meniere’s disease and vertigo. This drug insert does not indicate any discontinuation reaction or drug dependence effect, therefore, this drug can be discontinued at any time. Patients are advised to use the medication as prescribed by their physician and to consult their physician if they experience significant discomfort after discontinuing the medication.
Common adverse reactions to this product include nausea and vomiting, and occasional allergic reactions such as rash. Allergic to this product is prohibited, in addition, pregnant and lactating women, patients with a history of peptic ulcer or active peptic ulcer, patients with bronchial asthma, patients with adrenal medulla tumors use this drug with caution.
Because all medications have certain specifications and courses of treatment for the treatment of diseases, it is recommended that patients avoid using medications and stopping medications at their own discretion, so as not to affect the therapeutic effect.